AAAAAA

   
Results: 1-7 |
Results: 7
MANAGING ATTRIBUTE-VALUE CLINICAL-TRIALS DATA USING THE ACT DB CLIENT-SERVER DATABASE SYSTEM/
Authors: NADKARNI PM BRANDT C FRAWLEY S SAYWARD FG EINBINDER R ZELTERMAN D SCHACTER L MILLER PL
Citation: Pm. Nadkarni et al., MANAGING ATTRIBUTE-VALUE CLINICAL-TRIALS DATA USING THE ACT DB CLIENT-SERVER DATABASE SYSTEM/, Journal of the American Medical Informatics Association, 5(2), 1998, pp. 139-151
ETOPOSIDE BIOAVAILABILITY AFTER ORAL-ADMINISTRATION OF THE PRODRUG ETOPOSIDE PHOSPHATE IN CANCER-PATIENTS DURING A PHASE-I STUDY
Authors: CHABOT GG ARMAND JP TERRET C DEFORNI M ABIGERGES D WINOGRAD B IGWEMEZIE L SCHACTER L KAUL S ROPERS J BONNAY M
Citation: Gg. Chabot et al., ETOPOSIDE BIOAVAILABILITY AFTER ORAL-ADMINISTRATION OF THE PRODRUG ETOPOSIDE PHOSPHATE IN CANCER-PATIENTS DURING A PHASE-I STUDY, Journal of clinical oncology, 14(7), 1996, pp. 2020-2030
ETOPOSIDE PHOSPHATE - WHAT, WHY, WHERE, AND HOW
Authors: SCHACTER L
Citation: L. Schacter, ETOPOSIDE PHOSPHATE - WHAT, WHY, WHERE, AND HOW, Seminars in oncology, 23(6), 1996, pp. 1-7
AXIAL EXTRACTION OF HIGH-POWER MICROWAVES FROM RELATIVISTIC TRAVELING-WAVE AMPLIFIERS
Authors: NAQVI SA KERSLICK GS NATION JA SCHACTER L
Citation: Sa. Naqvi et al., AXIAL EXTRACTION OF HIGH-POWER MICROWAVES FROM RELATIVISTIC TRAVELING-WAVE AMPLIFIERS, Applied physics letters, 69(11), 1996, pp. 1550-1552
PHASE-I AND PHARMACOKINETIC STUDY OF ETOPOSIDE PHOSPHATE
Authors: BROOKS DJ SRINIVAS NR ALBERTA DS THOMAS T IGWEMZIE LM MCKINNEY LM RANDOLPH J SCHACTER L KAUL S BARBHAIYA RH
Citation: Dj. Brooks et al., PHASE-I AND PHARMACOKINETIC STUDY OF ETOPOSIDE PHOSPHATE, Anti-cancer drugs, 6(5), 1995, pp. 637-644
PHASE-I EVALUATION OF A WATER-SOLUBLE ETOPOSIDE PRODRUG, ETOPOSIDE PHOSPHATE, GIVEN AS A 5-MINUTE INFUSION ON DAY-1, DAY-3, AND DAY-5 IN PATIENTS WITH SOLID TUMORS
Authors: BUDMAN DR IGWEMEZIE LN KAUL S BEHR J LICHTMAN S SCHULMAN P VINCIGUERRA V ALLEN SL KOLITZ J HOCK K ONEILL K SCHACTER L BARBHAIYA RH
Citation: Dr. Budman et al., PHASE-I EVALUATION OF A WATER-SOLUBLE ETOPOSIDE PRODRUG, ETOPOSIDE PHOSPHATE, GIVEN AS A 5-MINUTE INFUSION ON DAY-1, DAY-3, AND DAY-5 IN PATIENTS WITH SOLID TUMORS, Journal of clinical oncology, 12(9), 1994, pp. 1902-1909
PHASE-II STUDY OF ELSAMITRUCIN IN NONSMALL CELL LUNG-CANCER
Authors: GOSS G LETENDRE F STEWART D SHEPHERD F SCHACTER L HOOGENDOORN P EISENHAUER E
Citation: G. Goss et al., PHASE-II STUDY OF ELSAMITRUCIN IN NONSMALL CELL LUNG-CANCER, Investigational new drugs, 12(4), 1994, pp. 315-317
Risultati: 1-7 |